Banu Arun

Questionnaire Administration

Cediranib

phase_2

atorvastatin calcium

phase_1

Tipifarnib

phase_1_2

Gemcitabine Hydrochloride

phase_1_2

Imatinib Mesylate

phase_2

Letrozole

phase_2

Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling

+2 more interventions

10 unique interventions2 categories

Analytics

Trial Phases

Phase 12

Phase 23

Trial Status

Completed3

Recruiting2

Role Distribution

Principal Investigator5

PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05126810Recruiting

Li-Fraumeni Syndrome

PrincipalinvestigatorStart date: 2022-11-03

NCT04090567Phase 2Recruiting

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more

PrincipalinvestigatorStart date: 2020-07-28

NCT00338728Phase 2Completed

Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveKIT Positive+4 more

PrincipalinvestigatorStart date: 2003-10-03

NCT00100750Phase 1/2Completed

Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer

Recurrent Breast CarcinomaStage IV Breast Cancer

Principalinvestigator

NCT00637481Phase 1Completed

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Atypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Anatomic Stage IV Breast Cancer AJCC v82 Prognostic Stage IV Breast Cancer AJCC v82 Advanced Breast Carcinoma1 Anatomic Stage III Breast Cancer AJCC v81 Anatomic Stage IIIA Breast Cancer AJCC v81 Anatomic Stage IIIB Breast Cancer AJCC v81 Anatomic Stage IIIC Breast Cancer AJCC v81 Atypical Ductal Breast Hyperplasia1

Affiliations

M.D. Anderson Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Breast CancerMetastatic Breast Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score2%

Norman Wolmark, MD

NSABP Foundation Inc

54 trials

Shared therapeutic areas:

Breast CancerStage IV Breast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score2%

Lizhi Niu, PhD

Fuda Cancer Hospital

31 trials

Shared therapeutic areas:

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

11 trials

Shared therapeutic areas:

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Ali MA Ismail, lecturer

Cairo University

27 trials

Shared therapeutic areas:

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Stage IV Breast Cancer

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

National Cancer Institute (NCI)

Worked with same sponsors:

Jamie Ostroff, PhD

Memorial Sloan Kettering Cancer Center

17 trials

Shared therapeutic areas:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)

Worked with same sponsors: